Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
and p110γ
InChi: InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5
Tifenazoxide (NN414
SR-4835 acts in synergy with DNA-damaging chemotherapy and PARP inhibitors and provokes triple-negative breast cancer (TNBC) cell death
SR9011 hydrochloride is a REV-ERBα/β agonist with IC50s of 790 nM and 560 nM for REV-ERBα and REV-ERBβ
JTE-952 vated Receptor-3 (PAR-3) (1-6) human TFA and p110γJTE 952 is a potent, oral active and selective Type II inhibitor of colony stimulating factor 1 receptor (CSF 1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse collagen induced model of arthritis. Product information CAS Number: 1255303 54 8 Molecular Weight: 518. 60 Formula: C30H34N2O6 Chemical Name: (2S) 3 {[2 (3 {4 [(4 cyclopropylphenyl)methoxy] 3
US$ 21.79
US$ 122.40
US$ 12.89
US$ 51.41
US$ 19.81
US$ 30.80